Please note that only limited free access to this journal is available in your country or territory.

To access the full content of this article you must purchase it (US$9.49). After payment of this one-off fee, you will gain unrestricted online access to the article and a PDF version sent to your email.

As part of our special introductory offer, after purchasing this article you will have unrestricted access to all the articles in this issue for free!

Registered users can purchase/access the article by logging in below. To register for free click here

Registered users login here:

  • Email Address:
     
  • Password:
     
  •  
If you have forgotten your password click here
0 rating

Diagnosis and Staging

Park JW, Jo MK, Lee HM.

Samsung Medical Center, Seoul, Korea.

 BJU Int 2009;103:615–9.

Editor’s note: Disease stage is the strongest predictor of outcome for patients with renal cell carcinoma (RCC). Approximately 30–35% of patients with RCC have localized disease at the time of diagnosis (Cancer Treat Rev 2007;33:1–8). A complete recovery is possible at this disease stage through radical nephrectomy. Owing to the frequently indolent course of the disease, surgical treatment of the metastases in advanced disease can improve the clinical outcome. Thus, early identification of the primary tumor or metastases can slow or prevent the development of the disease. The imaging methods commonly used for follow-up after radical nephrectomy include magnetic resonance imaging and bone scan to discover any new sites of disease. The role of positron-emission tomography (PET) in the staging of RCC is currently unclear owing to the discordant results published by different groups of investigators concerning the efficacy of PET for the identification the renal tumors and metastases.

Please login or register to continue reading this article
Return to top
Login/Register

Post Page On

LATEST ARTICLES

Our most popular articles